Novabridge Biosciences ADR (NBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBP | ACIU | ABEO | ||
| Company | Novabridge Biosciences ADR | AC Immune S.A. | Abeona Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.60 | 3.10 | 5.40 | ||
| High | 2.78 | 3.15 | 5.43 | ||
| Low | 2.60 | 2.91 | 5.29 | ||
| Latest | 2.67 | 3.07 | 5.38 | ||
| Change | +0.07 | -0.07 | -0.02 | ||
| % Change | +2.69% | -2.23% | -0.37% | ||
| Volume | 1,903,100 | 580,400 | 459,900 | ||
| 20-Day Average Volume | 942,395 | 256,225 | 1,237,630 | ||
| Previous Close | 2.60 | 3.14 | 5.40 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.50 | 2.97 | 4.72 | ||
| 20-Day Raw Stochastic | 83.82% | 55.32% | 94.65% | ||
| 20-Day Relative Strength | 46.25 | 51.38 | 60.69 | ||
| Weighted Alpha | +8.90 | +55.27 | +6.31 | ||
| Today's Opinion | 88% Sell | 32% Buy | 24% Sell | ||
| Previous Opinion | 88% Sell | 56% Buy | 24% Sell | ||
| Last Month's Opinion | 88% Sell | 64% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.88% since 04/09/26 | -9.71% since 04/09/26 | +5.08% since 04/09/26 | ||
| Low | 2.33 on 04/10/26 | 2.91 on 04/16/26 | 4.81 on 04/10/26 | ||
| High | 2.78 on 04/16/26 | 3.44 on 04/10/26 | 5.45 on 04/15/26 | ||
| 1-Month | |||||
| %Chg | -7.93% since 03/16/26 | -1.92% since 03/16/26 | +8.69% since 03/16/26 | ||
| Low | 2.10 on 03/30/26 | 2.55 on 03/30/26 | 4.23 on 03/30/26 | ||
| High | 3.03 on 03/18/26 | 3.49 on 04/09/26 | 5.45 on 04/15/26 | ||
| 3-Month | |||||
| %Chg | -28.42% since 01/16/26 | -12.54% since 01/16/26 | +2.48% since 01/16/26 | ||
| Low | 2.10 on 03/30/26 | 2.44 on 02/24/26 | 4.23 on 03/30/26 | ||
| High | 4.09 on 01/20/26 | 3.90 on 01/23/26 | 5.58 on 02/25/26 | ||
| 6-Month | |||||
| %Chg | -59.30% since 10/16/25 | +3.72% since 10/16/25 | -1.65% since 10/16/25 | ||
| Low | 2.10 on 03/30/26 | 2.44 on 02/24/26 | 4.00 on 11/07/25 | ||
| High | 6.39 on 10/17/25 | 4.00 on 10/29/25 | 5.68 on 01/16/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 308,783 | 312,446 | 306,924 | ||
| Shares Outstanding, K | 115,649 | 101,774 | 57,049 | ||
| Annual Sales | 0 | 4,310,000 | 5,820,000 | ||
| Annual Net Income | -46,270,000 | -85,030,000 | 71,180,000 | ||
| Last Quarter Sales | 0 | 450,000 | 5,420,000 | ||
| Last Quarter Net Income | -5,500,000 | -18,360,000 | -20,460,000 | ||
| 60-Month Beta | 1.74 | 1.63 | 1.22 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 08/20/25 | -0.18 on 03/13/26 | -0.34 on 03/17/26 | ||
| Latest Earnings Date | 05/21/26 | 04/29/26 | 05/21/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||